EPHA2 and nasopharyngeal carcinoma: Accordingly, inhibition of the c-Cbl-EphA2 interaction, due to molecular competitors such as the Ca2+ or phospholipid-binding protein Annexin A1 (ANXA1), increases EphA2 protein stability and promotes nasopharyngeal carcinoma in vitro and in vivo growth and metastasis [57].